Correlates of toxicity in metastatic melanoma patients treated with ipilimumab.

被引：0
|
作者：
Valpione, Sara
Pigozzo, Jacopo
Pasquali, Sandro
Piccin, Luisa
Mocellin, Simone
Campana, Luca Giovanni
Chiarion-Sileni, Vanna
机构：
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Univ Naples Federico II, Padua, Italy
[4] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[5] Veneto Oncol Inst, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e21010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.
    Valpione, Sara
    Martinoli, Chiara
    Fava, Paolo
    Quaglino, Pietro
    Ferrucci, Pier Francesco
    Mocellin, Simone
    Astrua, Chiara
    Campana, Luca Giovanni
    Pigozzo, Jacopo
    Chiarion-Sileni, Vanna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Clinical results and immunologic correlates in metastatic melanoma patients treated with ipilimumab
    Wolchok, Jedd D.
    Yuan, Jianda
    Gnjatic, Sacha
    Ritter, Gerd
    Ritter, Erica
    Gallardo, Humilidad
    Powell, Sarah
    Old, Lloyd J.
    Allison, James P.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 249 - 249
  • [3] Correlation between baseline parameters and overall survival in patients with advanced melanoma treated with ipilimumab.
    Foppen, Marnix Heimen Geukes
    Jordanova, Ekatarina S.
    Van Thienen, Johannes V.
    Punt, Simone
    Van de Wiel, Bart
    Haanen, John B. A. G.
    Blank, Christian U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Analysis of the impact of body mass index in the treatment of metastatic melanoma with ipilimumab.
    Games, Jessica Ribeiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] STUDY OF A COHORT OF PATIENTS WITH METASTATIC MELANOMA TREATED WITH IPILIMUMAB
    Roussel, A.
    Berthe, A.
    Quereux, G.
    Dreno, B. R. I.
    Thomare, P.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 36 - 36
  • [6] Genetic susceptibility to immune-related adverse events among melanoma patients treated with ipilimumab.
    Pluta, John
    Qian, Lu
    D'Andrea, Kurt
    Duan, Chunzhe
    Weathers, Benita
    Wind-Rotolo, Megan
    Kanetsky, Peter
    Nathanson, Katherine
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [7] Emotional and cognitive disturbances in long-term melanoma survivors treated with ipilimumab.
    Rogiers, Anne
    Awada, Gil
    Schwarze, Julia
    De Cremer, Jennifer
    Ben Salama, Laila
    Theuns, Peter
    Neyns, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [8] Nutrition-dependent Toxicity of Ipilimumab in Patients with metastatic Melanoma
    Majenka, P.
    Enk, A.
    Hassel, J.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 81 - 81
  • [9] EXPLORATORY LANDMARK ANALYSIS OF METASTATIC MELANOMA PATIENTS TREATED WITH IPILIMUMAB
    Kim, Hansoo
    Barzey, Victor
    Cook, Greg
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 312 - 312
  • [10] Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.
    Najjar, Yana G.
    Ding, Fei
    Lin, Yan
    Butterfield, Lisa H.
    Tarhini, Ahmad A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345